Likes offered: 0
Likes received: 0
Till date, several clinical trials have demonstrated the efficacy and therapeutic superiority (over conventional treatment options) of TIL therapies . Their tumor-cell killing efficiency is attributed to the fact that they are pre-sensitized to cancer specific antigens.Driven by the ongoing pace of innovation in this field, sufficient financial support from investors and encouraging clinical trial results, the TIL-based therapy
The global demand for biologics currently holds the largest share in the non-viral drug delivery domain and is expected to show the similar trend in the coming years.